1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1038/srep14257" target="_blank" rel="noreferrer noopener">http://doi.org/10.1038/srep14257</a>
Pages
14257–14257
Volume
5
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
TRPV4 channel activation selectively inhibits tumor endothelial cell proliferation.
Publisher
An entity responsible for making the resource available
Scientific reports
Date
A point or period of time associated with an event in the lifecycle of the resource
2015
2015-09
Subject
The topic of the resource
Animals; Antineoplastic Agents/pharmacology; Cell Proliferation/drug effects; Endothelial Cells/drug effects/metabolism; Leucine/analogs & derivatives/pharmacology; MAP Kinase Signaling System; Mice; Neoplasms/drug therapy/*metabolism/pathology; Neovascularization; Pathologic/drug therapy; Sulfonamides/pharmacology; TRPV Cation Channels/drug effects/genetics/*metabolism; Up-Regulation
Creator
An entity primarily responsible for making the resource
Thoppil Roslin J; Adapala Ravi K; Cappelli Holly C; Kondeti Vinay; Dudley Andrew C; Meszaros J Gary; Paruchuri Sailaja; Thodeti Charles K
Description
An account of the resource
Endothelial cell proliferation is a critical event during angiogenesis, regulated by both soluble factors and mechanical forces. Although the proliferation of tumor cells is studied extensively, little is known about the proliferation of tumor endothelial cells (TEC) and its contribution to tumor angiogenesis. We have recently shown that reduced expression of the mechanosensitive ion channel TRPV4 in TEC causes aberrant mechanosensitivity that result in abnormal angiogenesis. Here, we show that TEC display increased proliferation compared to normal endothelial cells (NEC). Further, we found that TEC exhibit high basal ERK1/2 phosphorylation and increased expression of proliferative genes important in the G1/S phase of the cell cycle. Importantly, pharmacological activation of TRPV4, with a small molecular activator GSK1016790A (GSK), significantly inhibited TEC proliferation, but had no effect on the proliferation of NEC or the tumor cells (epithelial) themselves. This reduction in TEC proliferation by TRPV4 activation was correlated with a decrease in high basal ERK1/2 phosphorylation. Finally, using a syngeneic tumor model revealed that TRPV4 activation, with GSK, significantly reduced endothelial cell proliferation in vivo. Our findings suggest that TRPV4 channels regulate tumor angiogenesis by selectively inhibiting tumor endothelial cell proliferation.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1038/srep14257" target="_blank" rel="noreferrer noopener">10.1038/srep14257</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
2015
Adapala Ravi K
Animals
Antineoplastic Agents/pharmacology
Cappelli Holly C
Cell Proliferation/drug effects
Department of Integrative Medical Sciences
Dudley Andrew C
Endothelial Cells/drug effects/metabolism
Kondeti Vinay
Leucine/analogs & derivatives/pharmacology
MAP Kinase Signaling System
Meszaros J Gary
Mice
NEOMED College of Medicine
Neoplasms/drug therapy/*metabolism/pathology
Neovascularization
Paruchuri Sailaja
Pathologic/drug therapy
Scientific reports
Sulfonamides/pharmacology
Thodeti Charles K
Thoppil Roslin J
TRPV Cation Channels/drug effects/genetics/*metabolism
Up-Regulation